A clinical study to evaluate the safety, efficacy, and feasibility of transplantation of autologous skeletal myoblast-derived cell sheets in patients with severe cardiomyopathy
Latest Information Update: 05 Apr 2021
At a glance
- Drugs Autologous skeletal myoblast derived cell sheet-Terumo (Primary)
- Indications Cardiomyopathies; Heart failure
- Focus Adverse reactions; Therapeutic Use
- 05 Apr 2021 New trial record